{"podcast":{"title":"Cell & Gene: The Podcast","slug":"cell-gene-the-podcast-4048431","podcast_index_feed_id":4048431,"rss_url":"https://rss.buzzsprout.com/1810482.rss","website_url":"https://www.buzzsprout.com/1810482","image_url":"https://storage.buzzsprout.com/f3p8rfd9kizh4zywm5msg5goq7nu?.jpg","author":"Erin Harris","episode_count":140,"summary":"Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.","last_synced_at":"2026-06-18T18:19:19.741610+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431"},"episode":{"title":"Scaling CRISPR for Rare Disease with Aurora Therapeutics' Dr. Edward Kaye","slug":"scaling-crispr-for-rare-disease-with-aurora-therapeutics-dr-edward-kaye","published_at":"2026-03-12T09:00:00+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/scaling-crispr-for-rare-disease-with-aurora-therapeutics-dr-edward-kaye","show_page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431","url":"https://www.buzzsprout.com/1810482/episodes/18821718-scaling-crispr-for-rare-disease-with-aurora-therapeutics-dr-edward-kaye.mp3","audio_url":"https://www.buzzsprout.com/1810482/episodes/18821718-scaling-crispr-for-rare-disease-with-aurora-therapeutics-dr-edward-kaye.mp3","summary":"We love to hear from our listeners. Send us a message. On episode 124 of Cell & Gene: The Podcast, Aurora Therapeutics' CEO Dr. Edward Kaye discusses the company’s strategy for translating CRISPR gene editing into scalable, commercially viable medicines for rare diseases. Aurora is initially targeting phenylketonuria (PKU) using a platform approach that leverages shared components, such as lipid nanoparticles and base editors, while customizing guide RNAs for specific mutations. Dr. Kaye ...","meta_description":"We love to hear from our listeners. Send us a message. On episode 124 of Cell & Gene: The Podcast, Aurora Therapeutics' CEO Dr. Edward Kaye discusses…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1684,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/scaling-crispr-for-rare-disease-with-aurora-therapeutics-dr-edward-kaye/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/scaling-crispr-for-rare-disease-with-aurora-therapeutics-dr-edward-kaye.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}